社区急性冠脉综合征后心血管风险评分的开发与验证
研究基于新西兰PREDICT初级保健数据库开发了PREDICT-ACS风险评分,用于预测社区管理的急性冠脉综合征后患者5年心血管事件风险。该评分利用社区常规数据即可计算,有助于指导患者风险管理沟通。
要点
- PREDICT-ACS评分可预测ACS后社区患者5年心血管事件风险。
- 推导与验证队列校准良好,区分度中等(c-statistic 0.69/0.68)。
- 评分仅需社区常规数据,便于临床沟通与决策。
核心结论
- PREDICT-ACS风险评分利用社区常规数据预测ACS后复发性临床事件风险。
- 评分在真实当代人群中推导并验证,可辅助社区ACS后患者的管理决策。
研究设计与样本
- 从新西兰PREDICT初级保健心血管风险管理数据库识别30-79岁既往ACS成人,链接国家死亡、住院、药品发放和区域实验室数据。
- 采用Cox模型纳入临床相关因素,估计至后续致死或非致死CVD事件时间,转化为5年风险评分。
- 外部验证在ACS后4个月评估的Coronary Disease Cohort Study患者中进行。
主要发现
- 推导队列中位估计5年CVD风险为24%(IQR 17%-35%)。
- 验证队列纳入2014例患者,72%男性,92%欧洲裔,中位年龄67岁,后续5年发生712例CVD事件。
- 验证队列中位估计5年风险为33%(IQR 24%-51%)。
- 风险评分在推导和验证队列中校准良好,Harrell's c-statistic分别为0.69和0.68。
临床怎么用
- PREDICT-ACS评分可用于社区ACS后患者,利用常规数据计算5年CVD风险。
- 评分结果可辅助医患沟通风险管理策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Following acute coronary syndrome (ACS), patients are managed long-term in the community, yet few tools are available to guide patient-clinician communication about risk management in that setting. We developed a score for predicting cardiovascular disease (CVD) risk among patients managed in the community after ACS. METHODS: Adults aged 30-79 years with prior ACS were identified from a New Zealand primary care CVD risk management database (PREDICT) with linkage to national mortality, hospitalisation, pharmaceutical dispensing and regional laboratory data. A Cox model incorporating clinically relevant factors was developed to estimate the time to a subsequent fatal or non-fatal CVD event and transformed into a 5-year risk score. External validation was performed in patients (Coronary Disease Cohort Study) assessed 4 months post-ACS. RESULTS: The PREDICT-ACS cohort included 13 703 patients with prior hospitalisation for ACS (median 1.9 years prior), 69% men, 58% European, median age 63 years, who experienced 3142 CVD events in the subsequent 5 years. Median estimated 5 year CVD risk was 24% (IQR 17%-35%). The validation cohort consisted of 2014 patients, 72% men, 92% European, median age 67 years, with 712 CVD events in the subsequent 5 years. Median estimated 5-year risk was 33% (IQR 24%-51%). The risk score was well calibrated in the derivation and validation cohorts, and Harrell's c-statistic was 0.69 and 0.68, respectively. CONCLUSIONS: The PREDICT-ACS risk score uses data routinely available in community care to predict the risk of recurrent clinical events. It was derived and validated in real-world contemporary populations and can inform management decisions with patients living in the community after experiencing an ACS.
引用
- Poppe KK, Doughty RN, Wells S, et al. Development and validation of a cardiovascular risk score for patients in the community after acute coronary syndrome. Heart. 2019. PMID: 31822573. doi:10.1136/heartjnl-2019-315809
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。